595 related articles for article (PubMed ID: 26679414)
21. General issues on microbial translocation in HIV-infected patients.
Novati S; Sacchi P; Cima S; Zuccaro V; Columpsi P; Pagani L; Filice G; Bruno R
Eur Rev Med Pharmacol Sci; 2015; 19(5):866-78. PubMed ID: 25807441
[TBL] [Abstract][Full Text] [Related]
22. HIV and hepatitis C coinfection: pathogenesis and microbial translocation.
Page EE; Nelson M; Kelleher P
Curr Opin HIV AIDS; 2011 Nov; 6(6):472-7. PubMed ID: 21918438
[TBL] [Abstract][Full Text] [Related]
23. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
24. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the orodigestive tract microbiome in HIV-infected patients.
Saxena D; Li Y; Devota A; Pushalkar S; Abrams W; Barber C; Corby P; Poles M; Phelan J; Malamud D
Oral Dis; 2016 Apr; 22 Suppl 1():73-8. PubMed ID: 27109275
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic avenues for restoring the gut microbiome in HIV infection.
Rosel-Pech C; Chávez-Torres M; Bekker-Méndez VC; Pinto-Cardoso S
Curr Opin Pharmacol; 2020 Oct; 54():188-201. PubMed ID: 33271427
[TBL] [Abstract][Full Text] [Related]
27. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
[TBL] [Abstract][Full Text] [Related]
29. A Summary of the Third Annual HIV Microbiome Workshop.
Williams B; Boucher C; Bushman F; Carrington-Lawrence S; Collman R; Dandekar S; Dang Q; Malaspina A; Paredes R; Wilson C; Nowak P; Klatt N; Lagenaur L; Landay A
AIDS Res Hum Retroviruses; 2018 Oct; 34(10):828-834. PubMed ID: 30105916
[TBL] [Abstract][Full Text] [Related]
30. Intestinal Dysbiosis, Barrier Dysfunction, and Bacterial Translocation Account for CKD-Related Systemic Inflammation.
Andersen K; Kesper MS; Marschner JA; Konrad L; Ryu M; Kumar Vr S; Kulkarni OP; Mulay SR; Romoli S; Demleitner J; Schiller P; Dietrich A; Müller S; Gross O; Ruscheweyh HJ; Huson DH; Stecher B; Anders HJ
J Am Soc Nephrol; 2017 Jan; 28(1):76-83. PubMed ID: 27151924
[TBL] [Abstract][Full Text] [Related]
31. Circulating LPS and (1→3)-β-D-Glucan: A Folie à Deux Contributing to HIV-Associated Immune Activation.
Ramendra R; Isnard S; Mehraj V; Chen J; Zhang Y; Finkelman M; Routy JP
Front Immunol; 2019; 10():465. PubMed ID: 30967860
[TBL] [Abstract][Full Text] [Related]
32. Microbiome alterations in HIV infection a review.
Williams B; Landay A; Presti RM
Cell Microbiol; 2016 May; 18(5):645-51. PubMed ID: 26945815
[TBL] [Abstract][Full Text] [Related]
33. Impact of antiretroviral drugs on the microbiome: unknown answers to important questions.
Pinto-Cardoso S; Klatt NR; Reyes-Terán G
Curr Opin HIV AIDS; 2018 Jan; 13(1):53-60. PubMed ID: 29028667
[TBL] [Abstract][Full Text] [Related]
34. HIV enteropathy and aging: gastrointestinal immunity, mucosal epithelial barrier, and microbial translocation.
Wang H; Kotler DP
Curr Opin HIV AIDS; 2014 Jul; 9(4):309-16. PubMed ID: 24871087
[TBL] [Abstract][Full Text] [Related]
35. Alcohol Use and Abuse Conspires With HIV Infection to Aggravate Intestinal Dysbiosis and Increase Microbial Translocation in People Living With HIV: A Review.
Yan J; Ouyang J; Isnard S; Zhou X; Harypursat V; Routy JP; Chen Y
Front Immunol; 2021; 12():741658. PubMed ID: 34975838
[TBL] [Abstract][Full Text] [Related]
36. Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS.
Ceccarelli G; Statzu M; Santinelli L; Pinacchio C; Bitossi C; Cavallari EN; Vullo V; Scagnolari C; d'Ettorre G
Expert Opin Biol Ther; 2019 Sep; 19(9):949-965. PubMed ID: 31260331
[No Abstract] [Full Text] [Related]
37. The Role of Microbial Translocation and Immune Activation in AIDS-Associated Non-Hodgkin Lymphoma Pathogenesis: What Have We Learned?
Epeldegui M; Hussain SK
Crit Rev Immunol; 2020; 40(1):41-51. PubMed ID: 32421978
[TBL] [Abstract][Full Text] [Related]
38. Microbial translocation in HIV infection: causes, consequences and treatment opportunities.
Sandler NG; Douek DC
Nat Rev Microbiol; 2012 Sep; 10(9):655-66. PubMed ID: 22886237
[TBL] [Abstract][Full Text] [Related]
39. Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design.
Routy JP; Mehraj V
AIDS Res Ther; 2017 Sep; 14(1):48. PubMed ID: 28893288
[TBL] [Abstract][Full Text] [Related]
40. Distinct intestinal microbial signatures linked to accelerated systemic and intestinal biological aging.
Singh S; Giron LB; Shaikh MW; Shankaran S; Engen PA; Bogin ZR; Bambi SA; Goldman AR; Azevedo JLLC; Orgaz L; de Pedro N; González P; Giera M; Verhoeven A; Sánchez-López E; Pandrea I; Kannan T; Tanes CE; Bittinger K; Landay AL; Corley MJ; Keshavarzian A; Abdel-Mohsen M
Microbiome; 2024 Feb; 12(1):31. PubMed ID: 38383483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
